| |
Clinical Track |
Interdisciplinary Track |
Ayahuasca Track |
| |
East Hall |
Jr. Ballroom |
Grand Ballroom |
| 7:00 |
Registration Opens |
| 7:30 |
Complimentary Continental Breakfast in the West Hall |
| 9:00 |
Jordi Riba, PhD: Fourteen Years of Clinical Research with Ayahuasca |
Amy Emerson: MAPS’ Drug Development Strategy: MDMA-Assisted Therapy for PTSD |
Jordi Riba, PhD: See Clinical Track. |
| 9:15 |
| 9:30 |
| 9:45 |
| 10:00 |
Ingmar Gorman: An Analysis of the Working Alliance in MDMA-Assisted Therapy |
| 10:15 |
| 10:30 |
Break |
| 11:00 |
Michael Mithoefer, MD and Annie Mithoefer BSN: MDMA-Assisted Therapy for PTSD: Current Research with Veterans, Firefighters, and Police Officers |
Matthew Johnson PhD: Pharmacokinetics and Phenomenology of Inhaled Salvinorin A in Humans |
Jacques Mabit, MD: Twenty Years at Takiwasi: Reflections on the Spiritual Dimension as the Interface Between Drug Addiction and Traditional Amazonian Medicine |
| 11:30 |
Jose Carlos Bouso PhD: 2C-B: 2C-B: Subjective Effects and Potential Clinical Uses |
| 12:00 |
James Fadiman: Scientific Problem Solving with Psychedelics |
Gerald Thomas, PhD, Philippe Lucas, MA, N. Rielle Capler, MHA, and Kenneth Tupper, PhD: Ayahuasca-Assisted Therapy in the Treatment of Addiction in a Canadian First Nations Band |
| 12:30 |
Lunch |
| 2:00 |
Peter Oehen, MD: MDMA-Assisted Therapy for PTSD: Results from the Swiss Pilot Study |
Bob Jesse: From the Johns Hopkins Psilocybin Findings to the Reconstruction of Religion |
Mitch Liester, MD and James Prickett, DO: Four Hypotheses Regarding Ayahuasca’s Mechanisms of Action in the Treatment of Addictions |
| 2:30 |
Jim Grigsby, PhD, Marcela Ot’alora, Keren Tzarfatyl, PhD (C), Andrew Feldmár, PhD, Ben Sessa, MD, and Martin Williams, PhD: Updates on MDMA-Assisted Therapy for PTSD Studies: Colorado, Israel, Canada, the UK, and Australia |
Anya Loizaga-Velder, PhD (C): The Therapeutic Potential of Ritual Ayahuasca Use for the Treatment of Substance Dependencies |
| 3:00 |
Panel: Q&A With All MDMA/PTSD Researchers |
Mary Cosimano & Brian Richards, MSW: Clinical Perspectives in Preparing and Managing High Dose Psilocybin Sessions: Insights from Johns Hopkins |
Gabor Mate, MD: Psychedelics in Unlocking the Unconscious: From Cancer to Addiction |
| 3:30 |
Alicia Danforth PhD (C): Findings from a Collective Case Study on the MDMA/Ecstasy Experiences of Adults on the Autism Spectrum |
| 4:00 |
Break |
| 4:30 |
Matt Baggott, PhD: Beyond Fear: MDMA and Emotion |
Katherine MacLean: What Can Buddhist Meditation Teach Us about Psychedelic Science? |
Josep María Fábregas, MD: Ayahuasca: Dope or Medicine? |
| 5:00 |
Franz Vollenweider, MD: The Neurobiology of Psychedelics: Implications for Mood Disorders |
Bill Richards, PhD: Psychedelic Psychotherapy: Insights from 25 Years of Research |
José Carlos Bouso, PhD: Ayahuasca and the Treatment of Drug Addiction: A Review of the Evidence and Proposals for the Future |
| 5:15 |
Brian Rush, PhD: Evaluating the Therapeutic Potential of Ayahuasca for Substance Use Problems |
| 6:00 |
Conference Day End |
| 7:00 |
Dinner |
| 8:30 |
Moonlight Plaza in the Marketplace |
